Table 2 Worksheet used to assess the potential clinical consequences due to anticancer medication errors
From: Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
Error number: Check the appropriate boxes | Physician assessment number: 1 or 2 | |
|---|---|---|
Potential severity according to the Medication Error Index (3) | ||
No consequences for the patient | ||
An error avoided that would not cause patient harm | ||
An error avoided that would require monitoring to confirm that it did not result in patient harm | ||
Temporary damage | Potential clinical consequences | Potential hospitalisation and treatment* |
An error avoided that could have contributed to temporary harm to the patient, requiring intervention | Acute renal failure | Hospitalisation |
Cardiac toxicity | Prolongation of the initial hospitalisation | |
Skin toxicity | New hospitalisation | |
An error avoided that could have contributed to temporary harm to the patient, requiring initial or prolonged hospitalisation | Neutropenia | Type of ward |
Thrombopenia | Standard hospitalisation unit | |
Anemia | Day-care unit | |
Febrile neutropenia | Intensive care unit | |
Neurotoxicity | Number of additional days of hospitalisation | |
Permanent damage | Hepatic cytolysis | Treatments |
An error avoided that could have contributed to permanent patient harm | Hepatic cholestasis | Platelet transfusions |
Compromised vital prognosis | Diarrhea | Erythrocyte transfusions |
An error avoided that could have required intervention necessary to sustain life | Vomiting | Granulocyte Colony Stimulating Factor |
Patient death | Other: | Parenteral nutrition |
Other: | ||
An error avoided that could have contributed to the patient's death |